Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
Germline mutations in BRCA1, BRCA2 and TP53 genes have been identified as one of the most important disease-causing issues in young breast cancer patients worldwide. The specific defective biological processes that trigger germline mutation-associated and -negative tumors remain unclear. To delineat...
Guardado en:
Autores principales: | Dirce Maria Carraro, Maria Aparecida Azevedo Koike Folgueira, Bianca Cristina Garcia Lisboa, Eloisa Helena Ribeiro Olivieri, Ana Cristina Vitorino Krepischi, Alex Fiorini de Carvalho, Louise Danielle de Carvalho Mota, Renato David Puga, Maria do Socorro Maciel, Rodrigo Augusto Depieri Michelli, Eduardo Carneiro de Lyra, Stana Helena Giorgi Grosso, Fernando Augusto Soares, Maria Isabel Alves de Souza Waddington Achatz, Helena Brentani, Carlos Alberto Moreira-Filho, Maria Mitzi Brentani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14eceaf0e1cf42b1a5282d76cdfa8691 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Kara N. Maxwell, et al.
Publicado: (2017) -
Poly (A)+ transcriptome assessment of ERBB2-induced alterations in breast cell lines.
por: Dirce Maria Carraro, et al.
Publicado: (2011) -
Clinical consequences of BRCA2 hypomorphism
por: Laia Castells-Roca, et al.
Publicado: (2021) -
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Ilirjana Bajrami, et al.
Publicado: (2021) -
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
por: Ana Blanco, et al.
Publicado: (2013)